Difference between revisions of "Covariates Rationale"
Line 2: | Line 2: | ||
==QIBA FDG-PET/CT Covariates Rationale Technical Subcommittee Charge== | ==QIBA FDG-PET/CT Covariates Rationale Technical Subcommittee Charge== | ||
+ | Covariates Rationale Technical Subcommittee | ||
+ | Yuying Hwang, PhD, Subcommittee Chair | ||
+ | (yhwang@amgen.com) | ||
+ | |||
+ | The objective of this subcommittee is to identify clinically significant covariates such as patient compliance parameters, scan conditions, and intrinsic system operating parameters. | ||
+ | |||
+ | |||
+ | Create standardized forms to capture all covariates | ||
+ | • Patient Compliance Parameters | ||
+ | • Scan Conditions | ||
+ | • Intrinsic System Operating Parameters | ||
+ | Construct policy guidelines for manufacturers to set requirement on recording and normalizing these covariates. | ||
+ | Distribute the forms to PET centers for recording | ||
+ | Educate the sites on importance of these covariates | ||
+ | These covariates may be used to find if there is a relationship between any parameter with the study results. | ||
Revision as of 20:22, 9 March 2009
Back to FDG-PET
QIBA FDG-PET/CT Covariates Rationale Technical Subcommittee Charge
Covariates Rationale Technical Subcommittee Yuying Hwang, PhD, Subcommittee Chair (yhwang@amgen.com)
The objective of this subcommittee is to identify clinically significant covariates such as patient compliance parameters, scan conditions, and intrinsic system operating parameters.
Create standardized forms to capture all covariates
• Patient Compliance Parameters
• Scan Conditions
• Intrinsic System Operating Parameters
Construct policy guidelines for manufacturers to set requirement on recording and normalizing these covariates.
Distribute the forms to PET centers for recording
Educate the sites on importance of these covariates
These covariates may be used to find if there is a relationship between any parameter with the study results.